Tag: Severe
Ampio says its study on Covid-19 patients proceeding to full open...
Ampio Pharmaceuticals Inc has announced that its AP-014 Phase I inhaled Ampion clinical study in Covid-19 patients is proceeding to full open enrollment after...
